“…Numerous abnormalities have been described in both T‐cell and NK function ( Stupp et al , 1978 ; Rambotti et al , 1982 ; Chang et al , 1989 ; Verfaillie et al , 1990 ; Rajaram et al , 1990 ; Sorskaar et al , 1986 ; Colombat et al , 1988 ; Fontana et al , 1989 ; Hamblin, 1992; Ogata et al , 1995 ). Similar abnormalities are also reported in association with solid tumours, and studies have shown an inherent defect in activation in both NK and T cells from patients with advanced cancer ( Takasugi et al , 1977 ; Whitcomb & Parker, 1977; Miescher et al , 1986 ; Maccubbin et al , 1989 ). It has been suggested that the mechanism underlying the signalling defects observed may be caused by loss of components of the T‐cell receptor (TCR) ( Mizoguchi et al , 1992 ; Finke et al , 1993 ; Nakagomi et al , 1993 ; Matsuda et al , 1995 ; Zier et al , 1996 ) and Fc receptors on NK cells ( Nakagomi et al , 1993 ; Matsuda et al , 1995 ).…”